Targeting TIM-1 on CD4 T cells depresses macrophage activation and overcomes ischemia-reperfusion injury in mouse orthotopic liver transplantation
- PMID: 23137033
- PMCID: PMC3535503
- DOI: 10.1111/j.1600-6143.2012.04316.x
Targeting TIM-1 on CD4 T cells depresses macrophage activation and overcomes ischemia-reperfusion injury in mouse orthotopic liver transplantation
Abstract
Hepatic injury due to cold storage followed by reperfusion remains a major cause of morbidity and mortality after orthotopic liver transplantation (OLT). CD4 T cell TIM-1 signaling costimulates a variety of immune responses in allograft recipients. This study analyzes mechanisms by which TIM-1 affects liver ischemia-reperfusion injury (IRI) in a murine model of prolonged cold storage followed by OLT. Livers from C57BL/6 mice, preserved at 4°C in the UW solution for 20 h, were transplanted to syngeneic recipients. There was an early (1 h) increased accumulation of TIM-1+ activated CD4 T cells in the ischemic OLTs. Disruption of TIM-1 signaling with a blocking mAb (RMT1-10) ameliorated liver damage, evidenced by reduced sALT levels and well-preserved architecture. Unlike in controls, TIM-1 blockade diminished OLT expression of Tbet/IFN-γ, but amplified IL-4/IL-10/IL-22; abolished neutrophil and macrophage infiltration/activation and inhibited NF-κB while enhancing Bcl-2/Bcl-xl. Although adoptive transfer of CD4 T cells triggered liver damage in otherwise IR-resistant RAG(-/-) mice, adjunctive TIM-1 blockade reduced Tbet transcription and abolished macrophage activation, restoring homeostasis in IR-stressed livers. Further, transfer of TIM-1(Hi) CD4+, but not TIM-1(Lo) CD4+ T cells, recreated liver IRI in RAG(-/-) mice. Thus, TIM-1 expressing CD4 T cells are required in the mechanism of innate immune-mediated hepatic IRI in OLTs.
© Copyright 2012 The American Society of Transplantation and the American Society of Transplant Surgeons.
Conflict of interest statement
Figures







Similar articles
-
Negative CD4 + TIM-3 signaling confers resistance against cold preservation damage in mouse liver transplantation.Am J Transplant. 2015 Apr;15(4):954-964. doi: 10.1111/ajt.13067. Epub 2015 Feb 12. Am J Transplant. 2015. PMID: 25676534 Free PMC article.
-
T-cell immunoglobulin and mucin domain 4 (TIM-4) signaling in innate immune-mediated liver ischemia-reperfusion injury.Hepatology. 2014 Dec;60(6):2052-2064. doi: 10.1002/hep.27334. Epub 2014 Oct 29. Hepatology. 2014. PMID: 25066922 Free PMC article.
-
Recipient T cell TIM-3 and hepatocyte galectin-9 signalling protects mouse liver transplants against ischemia-reperfusion injury.J Hepatol. 2015 Mar;62(3):563-72. doi: 10.1016/j.jhep.2014.10.034. Epub 2014 Oct 31. J Hepatol. 2015. PMID: 25450716 Free PMC article.
-
CD4+ T Cell NRF2 Signaling Improves Liver Transplantation Outcomes by Modulating T Cell Activation and Differentiation.Antioxid Redox Signal. 2023 Mar;38(7-9):670-683. doi: 10.1089/ars.2022.0094. Epub 2023 Mar 1. Antioxid Redox Signal. 2023. PMID: 36070449 Free PMC article. Review.
-
Heme Oxygenase-1 in liver transplant ischemia-reperfusion injury: From bench-to-bedside.Free Radic Biol Med. 2020 Sep;157:75-82. doi: 10.1016/j.freeradbiomed.2020.02.012. Epub 2020 Feb 19. Free Radic Biol Med. 2020. PMID: 32084514 Free PMC article. Review.
Cited by
-
Negative CD4 + TIM-3 signaling confers resistance against cold preservation damage in mouse liver transplantation.Am J Transplant. 2015 Apr;15(4):954-964. doi: 10.1111/ajt.13067. Epub 2015 Feb 12. Am J Transplant. 2015. PMID: 25676534 Free PMC article.
-
Immune Regulation and Antitumor Effect of TIM-1.J Immunol Res. 2016;2016:8605134. doi: 10.1155/2016/8605134. Epub 2016 Jun 20. J Immunol Res. 2016. PMID: 27413764 Free PMC article. Review.
-
Histone Methylation Inhibitor DZNep Ameliorated the Renal Ischemia-Reperfusion Injury via Inhibiting TIM-1 Mediated T Cell Activation.Front Med (Lausanne). 2020 Jul 10;7:305. doi: 10.3389/fmed.2020.00305. eCollection 2020. Front Med (Lausanne). 2020. PMID: 32754604 Free PMC article.
-
T-cell immunoglobulin and mucin domain 4 (TIM-4) signaling in innate immune-mediated liver ischemia-reperfusion injury.Hepatology. 2014 Dec;60(6):2052-2064. doi: 10.1002/hep.27334. Epub 2014 Oct 29. Hepatology. 2014. PMID: 25066922 Free PMC article.
-
Equilibrative nucleoside transporter (ENT)-1-dependent elevation of extracellular adenosine protects the liver during ischemia and reperfusion.Hepatology. 2013 Nov;58(5):1766-78. doi: 10.1002/hep.26505. Epub 2013 Sep 24. Hepatology. 2013. PMID: 23703920 Free PMC article.
References
-
- Caldwell CC, Tschoep J, Lentsch AB. Lymphocyte function during hepatic ischemia/reperfusion injury. J Leukoc Biol. 2007;82:457–464. - PubMed
-
- Shen XD, Ke B, Zhai Y, et al. Stat4 and Stat6 signaling in hepatic ischemia/reperfusion injury in mice: HO-1 dependence of Stat4 disruption-mediated cytoprotection. Hepatology. 2003;37:296–303. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials